Allodynia
Not yet recruitingSafety and effectiveness study of PN6047 HCl in adults with peripheral neuropathic pain and mechanical allodynia
- Disease:Allodynia
- Substances:–
Czechia- Participants:18–64 years · 65+ years
- Sponsor:Pharmnovo AB
Rare diseases
Investigational molecules
Locations
Scheeletorget 1, 223 63 Lund, Sweden
Pharmnovo AB is active in clinical research focused on peripheral neuropathic pain, with particular attention to pain states marked by mechanical allodynia. Its research activity is centered on understanding and addressing sensory pain disorders that arise from peripheral nerve dysfunction.
The sponsor’s clinical interest is directed toward conditions in which normally non-painful stimuli trigger pain responses, reflecting a therapeutic focus on difficult-to-treat neuropathic pain syndromes.
Pharmnovo AB runs clinical trials in conditions such as Allodynia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.